Empyrean Capital Partners’s CVS Health CVS Stock Holding History

Empyrean Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,160,000	Closed	-$92.1M	–	128
2025 Q4	$92.1M	Buy	1,160,000 +117,500	+11%	+$9.26M	3.21%	6
2025 Q3	$78.6M	Buy	1,042,500 +180,500	+21%	+$12.4M	3.15%	8
2025 Q2	$59.5M	Sell	862,000 -669,000	-44%	-$43.9M	2%	12
2025 Q1	$104M	Buy	1,531,000 +641,000	+72%	+$38.4M	3.68%	7
2024 Q4	$40M	Buy	+890,000	New	+$49.9M	1.82%	18

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Empyrean Capital Partners's CVS Position: Q1 2026 in Review

Empyrean Capital Partners sold out of CVS Health (CVS) in Q1 2026, closing a stake of 1,160,000 shares — an estimated $92.1M sold.

Empyrean Capital Partners first reported a position in CVS in Q4 2024 and held it in 5 quarters. The position peaked at $104M in Q1 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Empyrean Capital Partners reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Empyrean Capital Partners sold 1,160,000 CVS Health shares in Q1 2026, an estimated $92.1M.
Empyrean Capital Partners first reported a position in CVS Health in Q4 2024 and held it in 5 quarters.
Empyrean Capital Partners's CVS Health position peaked at $104M in Q1 2025.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Empyrean Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.